You are here


Adams RA, Schachtrup C, Davalos D, Tsigelny I, Akassoglou K. "Fibrinogen signal transduction as a mediator and therapeutic target in inflammation: lessons from multiple sclerosis." Curr. Med. Chem.. 2007;14(27):2925-36.
Mueller-Steiner S, Zhou Y, Arai H, et al. "Antiamyloidogenic and neuroprotective functions of cathepsin B: implications for Alzheimer's disease." Neuron. 2006;51(6):703-14.
Arthur DB, Akassoglou K, Insel PA. "P2Y2 and TrkA receptors interact with Src family kinase for neuronal differentiation." Biochem. Biophys. Res. Commun.. 2006;347(3):678-82.
Palop JJ, Chin J, Mucke L. "A network dysfunction perspective on neurodegenerative diseases." Nature. 2006;443(7113):768-73.
Finkbeiner S, Cuervo AMaria, Morimoto RI, Muchowski PJ. "Disease-modifying pathways in neurodegeneration." J. Neurosci.. 2006;26(41):10349-57.
M Beal F, Bossy-Wetzel E, Finkbeiner S, et al. "Common threads in neurodegenerative disorders of aging." Alzheimers Dement. 2006;2(4):322-6.
Roberson ED, Mucke L. "100 years and counting: prospects for defeating Alzheimer's disease." Science. 2006;314(5800):781-4.
Tesseur I, Zou K, Esposito L, et al. "Deficiency in neuronal TGF-beta signaling promotes neurodegeneration and Alzheimer's pathology." J. Clin. Invest.. 2006;116(11):3060-9.
Choi D-S, Wang D, Yu G-Q, et al. "PKCepsilon increases endothelin converting enzyme activity and reduces amyloid plaque pathology in transgenic mice." Proc. Natl. Acad. Sci. U.S.A.. 2006;103(21):8215-20.
Xu Q, Bernardo A, Walker D, Kanegawa T, Mahley RW, Huang Y. "Profile and regulation of apolipoprotein E (ApoE) expression in the CNS in mice with targeting of green fluorescent protein gene to the ApoE locus." J. Neurosci.. 2006;26(19):4985-94.
Mahley RW, Huang Y, Weisgraber KH. "Putting cholesterol in its place: apoE and reverse cholesterol transport." J. Clin. Invest.. 2006;116(5):1226-9.
Morris R, Mucke L. "Alzheimer's disease: A needle from the haystack." Nature. 2006;440(7082):284-5.
Mahley RW, Bersot TP. "High density lipoprotein cholesterol in coronary artery patients: is it as low as expected?" Anadolu Kardiyol Derg. 2006;6(1):94-6; author reply 96.
Safar JG, Wille H, Geschwind MD, et al. "Human prions and plasma lipoproteins." Proc. Natl. Acad. Sci. U.S.A.. 2006;103(30):11312-7.
Rao VR, Pintchovski SA, Chin J, Peebles CL, Mitra S, Finkbeiner S. "AMPA receptors regulate transcription of the plasticity-related immediate-early gene Arc." Nat. Neurosci.. 2006;9(7):887-95.
Bradley J, Carter SR, Rao VR, Wang J, Finkbeiner S. "Splice variants of the NR1 subunit differentially induce NMDA receptor-dependent gene expression." J. Neurosci.. 2006;26(4):1065-76.
Huang Y. "Apolipoprotein E and Alzheimer disease." Neurology. 2006;66(2 Suppl 1):S79-85.
Hodoglugil U, Tanyolaç S, Williamson DW, Huang Y, Mahley RW. "Apolipoprotein A-V: a potential modulator of plasma triglyceride levels in Turks." J. Lipid Res.. 2006;47(1):144-53.
Ji Z-S, Müllendorff K, Cheng IH, R Miranda D, Huang Y, Mahley RW. "Reactivity of apolipoprotein E4 and amyloid beta peptide: lysosomal stability and neurodegeneration." J. Biol. Chem.. 2006;281(5):2683-92.
Arthur DB, Georgi S, Akassoglou K, Insel PA. "Inhibition of apoptosis by P2Y2 receptor activation: novel pathways for neuronal survival." J. Neurosci.. 2006;26(14):3798-804.
Mahley RW, Weisgraber KH, Huang Y. "Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease." Proc. Natl. Acad. Sci. U.S.A.. 2006;103(15):5644-51.